Minimally-invasive Stabilization of Pelvic Metastases With Photodynamic Nails: A Multi-center Prospective Study of Functional Outcome

Part of paid clinical trials in Houston, Texas.

Sponsor: M.D. Anderson Cancer Center
Study ID: NCT06083896
Phase: PHASE1
Status: Recruiting

Apply to this trial

Conditions

Pelvic Metastasis

Eligibility Criteria

Sex: ALL
Age: 18 Years - N/A
Healthy Volunteers: Not accepted

Interventions

Photodynamic nails — PROCEDURE
stab incision is made at the entry site

Study Details

Determine whether patients exhibit early functional improvement after minimally-invasive placement of Illuminoss photodynamic nails for peri-acetabular pelvic metastasis at 3 months following procedure

Key Dates

Start date: Oct 6, 2023
Status verified: Feb 2026
Primary completion: Jan 1, 2027
Completion: Jan 1, 2029

Study Design

Enrollment: 50 participants (estimated)
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Primary Outcome Measure

Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 [ Time Frame: Through study completion, up to one year ]

Central Contacts

Patrick Lin, MD
(713) 745-0088
[email protected]

Locations (1)

Facility	City	State	ZIP	Site coordinators
MD Anderson Cancer Center	Houston	Texas	77030	Patrick Lin, MD [email protected] 713-745-0088 Patrick Lin, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By research site

MD Anderson Cancer Center· Houston, TX